|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED STATEMENT OF OPERATIONS, CONSOLIDATED BALANCE SHEET, AND
CONSOLIDATED STATEMENT OF CASH FLOWS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000815094
<NAME> ABIOMED, INC.
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 90,987
<SECURITIES> 8,917
<RECEIVABLES> 8,233
<ALLOWANCES> 184
<INVENTORY> 3,912
<CURRENT-ASSETS> 112,448
<PP&E> 10,523
<DEPRECIATION> 6,270
<TOTAL-ASSETS> 4,253
<CURRENT-LIABILITIES> 123,787
<BONDS> 0
0
0
<COMMON> 206
<OTHER-SE> 115,914
<TOTAL-LIABILITY-AND-EQUITY> 123,787
<SALES> 12,844
<TOTAL-REVENUES> 12,844
<CGS> 13,516
<TOTAL-COSTS> 19,452
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (3,143)
<INCOME-PRETAX> (3,465)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,465)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,465)
<EPS-BASIC> (0.17)
<EPS-DILUTED> (0.17)
</TABLE>
|
|